Patients receiving a single 40 mg injection of the investigational drug Zilretta, a sustained-release steroid product for moderate-to-severe knee osteoarthritis pain manufactured by Flexion Therapeutics, showed pain reduction of about 50 percent compared with those given placebo.

Click here to learn more.